Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Teladoc to Participate in Upcoming Investor Conference
-
Teladoc to Participate in Upcoming Investor Conference
-
Clean Harbors to Present at Canaccord Genuity’s 38th Annual Growth Conference
-
SMTC Corporation to Announce Second Quarter 2018 Results on August 8 and Participate in Canaccord Genuity Growth Conference on August 9
-
IPG Photonics to Participate in Upcoming Investor Conferences
-
DexCom Announces Upcoming Conference Presentation
-
IMV Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
-
AxoGen, Inc. to Present at Canaccord Genuity Growth Conference
-
AxoGen, Inc. to Present at Canaccord Genuity Growth Conference
-
Cubic to Present at Canaccord Genuity 38th Annual Growth Conference
-
Qualcomm ends $44 billion NXP bid after failing to win China approval
-
Cornerstone to Present at Upcoming Investor Conferences
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $70 at Canaccord Genuity
-
Alphabet (GOOGL) PT Raised to $1,170 at Canaccord Genuity
-
T2 Biosystems to Participate in Two Upcoming Conferences
-
Canaccord Genuity Starts Neuronetics (STIM) at Buy
-
H1 2018 Post-close Trading Update and notice of results
-
BioScrip to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
DHX Media Closes Sale to Sony of Minority Stake in Peanuts
-
Attunity to Participate in the Canaccord Genuity 38th Annual Growth Conference on August 8th
-
Quest Diagnostics (DGX) PT Raised to $122 at Canaccord Genuity
-
Canaccord Genuity Starts Forty Seven Inc. (FTSV) at Buy
-
Canaccord Genuity Starts EverQuote (EVER) at Buy
-
I.D. Systems to Present at Canaccord Genuity 38th Annual Growth Conference on August 9, 2018
-
Microsoft shares at all-time high after bumper results
-
TransGlobe Energy Corporation Announces Operations Update
-
Penumbra, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Mallinckrodt plc (MNK) PT Raised to $22 at Canaccord Genuity
-
Ericsson (ERIC) PT Raised to $8.50 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Upgrades MeetMe (MEET) to Buy
-
Cara Therapeutics (CARA) Prices 4.5M Share Common Offering at $19/Sh
-
Nano Dimension to Present at Canaccord 38th Annual Growth Conference
-
Nano Dimension to Present at Canaccord 38th Annual Growth Conference
-
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
-
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
-
Vigil Health Solutions Announces Normal Course Issuer Bid
-
Maricann Group Announces Private Placement of Units
-
Canaccord Genuity Group Inc. Access to First Quarter Fiscal 2019 Results Information
-
Absolute to Present at the 38th Annual Canaccord Genuity Growth Conference
-
BELGRAVIA corporate update
-
Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference
-
Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference
-
Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018
-
Cara Therapeutics (CARA) Announces Proposed 4.5M Share Common Offering
-
Cara Therapeutics Announces Proposed Offering of Common Stock
-
Cara Therapeutics Announces Proposed Offering of Common Stock
-
Whitney Ijem Joins Guggenheim Securities as Biotech Analyst


